Cited by 315Muscle Physiology and DisordersNutrition and Health in AgingBone Metabolism and Diseases

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass

Open access

Bonnet, Nicolas, Bourgoin, Lucie, Biver, Emmanuel, Douni, Eleni, Ferrari, Serge·2019·Journal of Clinical Investigation

Open this paper in CoChat — free account Open PDF

Abstract

Receptor activator of Nfkb ligand (RANKL) activates, while osteoprotegerin (OPG) inhibits, osteoclastogenesis. In turn a neutralizing Ab against RANKL, denosumab improves bone strength in osteoporosis. OPG also improves muscle strength in mouse models of Duchenne's muscular dystrophy (mdx) and denervation-induce atrophy, but its role and mechanisms of action on muscle weakness in other conditions remains to be investigated. We investigated the effects of RANKL inhibitors on muscle in osteoporotic women and mice that either overexpress RANKL (HuRANKL-Tg+), or lack Pparb and concomitantly develop sarcopenia (Pparb-/-). In women, denosumab over 3 years improved appendicular lean mass and handgrip strength compared to no treatment, whereas bisphosphonate did not. HuRANKL-Tg+ mice displayed lower limb force and maximal speed, while their leg muscle mass was diminished, with a lower number of type I and II fibers. Both OPG and denosumab increased limb force proportionally to the increase in muscle mass. They markedly improved muscle insulin sensitivity and glucose uptake, and decrease anti-myogenic and inflammatory gene expression in muscle, such as myostatin and protein tyrosine phosphatase receptor-γ. Similarly, in Pparb-/-, OPG increased muscle volume and force, while also normalizing their insulin signaling and higher expression of inflammatory genes in skeletal muscle. In conclusions, RANKL deteriorates, while its inhibitor improves, muscle strength and insulin sensitivity in osteoporotic mice and humans. Hence denosumab could represent a novel therapeutic approach for sarcopenia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci125915

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010
Mechanisms of Disease: is osteoporosis the obesity of bone?
Rosen, C. J., & Bouxsein, M. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0070 · Cited by 974
Role of RANK ligand in mediating increased bone resorption in early postmenopausal women
Eghbali-Fatourechi, G., Khosla, S., Sanyal, A., Boyle, W. J., Lacey, D. L., & Riggs, B. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17215 · Cited by 825 · cited 1×
“Increased expression of receptor activator of nuclear factor kappa-B ligand (RANKL) in postmenopausal women plays a central role in the development of osteoporosis (5).”
Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab
Lacey, D. L., Boyle, W. J., Simonet, W. S., Kostenuik, P. J., Dougall, W. C., Sullivan, J. K., Martín, J. S., & Dansey, R. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3705 · Cited by 698
Age-associated declines in muscle mass, strength, power, and physical performance: impact on fear of falling and quality of life
Trombetti, A., Reid, K. F., Hars, M., Herrmann, F. R., Pasha, E. P., Phillips, E. M., & Fielding, R. A. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3236-5 · Cited by 479
Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor‐κΒ
LANGEN, R. C. J., Schols, A. M. W. J., KELDERS, M. C. J. M., Wouters, E. F. �., & Janssen-Heininger, Y. M. W. (2001) · The FASEB Journal · doi:10.1096/fj.00-0463 · Cited by 436
Microbiota depletion promotes browning of white adipose tissue and reduces obesity
Suárez-Zamorano, N., Fabbiano, S., Chevalier, C., Stojanović, O., Colin, D. J., Stevanović, A., Veyrat-Durebex, C., Tarallo, V., Rigo, D., Germain, S., et al. (2015) · Nature Medicine · doi:10.1038/nm.3994 · Cited by 403

Show all 41 references

Sorted by citations

Items 201–300 of 315

Osteosarcopenia School
Dionyssiotis, Y., Prokopidis, K., Vorniotakis, P., & Bakas, E. (2021) · Journal of Frailty Sarcopenia and Falls · doi:10.22540/jfsf-06-231 · Cited by 4
Einfluss von Osteoporose auf physische Leistungsparameter von Personen im mittleren und höheren Lebensalter – eine Querschnittstudie
Schröder, G., Flachsmeyer, D., Bende, A., Andresen, J. R., Andresen, R., & Schober, H. (2022) · Die Orthopädie · doi:10.1007/s00132-022-04329-3 · Cited by 4
Hyperglycaemia induced osteoporosis: Is there a hope with dipeptidyl peptidase-4 inhibitors?
Ahmed, F., Ahmad, S. S., Alam, M. M., Khatoon, A., Ali, R., Ahmad, J., Amina, N., Najmi, A. K., & Khan, M. A. (2023) · Health Sciences Review · doi:10.1016/j.hsr.2023.100135 · Cited by 4
The comparative effect of teriparatide and denosumab on activins, follistatins, and inhibins in women with postmenopausal osteoporosis
Anastasilakis, A. D., Pοlyzos, S. A., Makras, P., Savvidis, M. S., & Mantzoros, C. S. (2024) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjae106 · Cited by 4
Beyond mineralisation: metabolic functions for matrix mineralisation regulators
Roberts, F. L., Markby, G. R., Dillon, S., Farquharson, C., & MacRae, V. E. (2020) · Journal of Endocrinology · doi:10.1530/joe-19-0460 · Cited by 4
Citrate‐Enhanced PCL Scaffolds for Bone Tissue Engineering
Muşmula, M., Sogut, O., Aru, B., Gürel, G., Sezer, S., Demirel, G. Y., & Sezer, Ü. A. (2025) · Advanced Materials Interfaces · doi:10.1002/admi.202500184 · Cited by 3
M2-exo promote orthodontic bone remodeling via the MeCP2-TCF20-HDAC1 axis
Chen, M., Li, Y., Yang, Z.-J., Chen, M., Li, J., Bao, G., Ma, L., & Hu, J. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04633-7 · Cited by 4
Effects of anti-RANKL, zoledronate, or combination therapy in a mouse model of fibrous dysplasia: a preclinical study
Palmisano, B., Tavanti, C., Farinacci, G., Corsi, A., Serafini, M., Appelman‐Dijkstra, N. M., & Riminucci, M. (2026) · Journal of Bone and Mineral Research · doi:10.1093/jbmr/zjag037 · Cited by 3
Immunometabolic mechanisms of osteosarcopenic obesity: chronic inflammation, trained immunity, and systemic immune dysregulation
Jiang, H., Zhang, Y., Luo, Z., Tang, X., 赫一佑, & Hao, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1808488 · Cited by 5
Why Osteosarcopenia Matters: Clinical and Investigative Implications
Bonamigo, E. L., Maia, M. N., de Oliveira, R. P. C., Mestriner, R. G., Aprahamian, I., & Duque, G. (2026) · European Journal of Clinical Investigation · doi:10.1111/eci.70221 · Cited by 4
Mental and physical conditions associated with physical inactivity among Farhangian University students during virtual classes: A cross-sectional study
Firouzjah, M. H., Pourazar, M., & Kakvandi, S. N. (2023) · Frontiers in Psychology · doi:10.3389/fpsyg.2023.1094683 · Cited by 3
Potential application of anti-osteoporotic therapy to relieve sarcopenia in the elderly
Li, Y., Li, X., Kong, Z., Yin, B., Lan, Z., & Li, H. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001352 · Cited by 3
RANKL/RANK contributes to the pathological process of type 2 diabetes mellitus through TRAF3 activation of NIK
Yu, J., Tian, N., Hu, Y., & Jin, T. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113008 · Cited by 3
The skeleton: an overlooked regulator of systemic glucose metabolism in cancer?
Ronghe, R., & Tavares, A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1481241 · Cited by 4
Research Progress on the Influence of Novel Targeted Drugs for Osteoporosis on Glucose Metabolism
Meng, L., Sun, L., & Li, M. (2025) · Biomolecules · doi:10.3390/biom15030331 · Cited by 4
Calf circumference predicts changes of bone mineral density in postmenopausal osteoporotic women receiving denosumab
Oliveri, C. V., Xourafa, A., Morabito, N., Giovanni, A. D., LUPO, E. A. B., Basile, G., Gaudio, A., & Catalano, A. (2025) · Aging Clinical and Experimental Research · doi:10.1007/s40520-025-02989-7 · Cited by 3
The Role of Bone in Muscle Wasting
Klein, G. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010392 · Cited by 2
Low Bone Turnover Due to Hypothyroidism or Anti-Resorptive Treatment Does Not Affect Whole-Body Glucose Homeostasis in Male Mice
Lademann, F., Rauner, M., Bonnet, N., Hofbauer, L. C., & Tsourdi, E. A. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091462 · Cited by 3
Cyclin A1 (CCNA1) inhibits osteoporosis by suppressing transforming growth factor-beta (TGF-beta) pathway in osteoblasts
Du, X., Zang, C., & Wang, Q. (2024) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-024-07303-6 · Cited by 3
The role of anti-osteoporosis drugs in fall risk
Voltan, G., & Veronese, N. (2024) · International Journal of Bone Fragility · doi:10.57582/ijbf.240401.002 · Cited by 3
Falls and fracture risk assessment—The role of osteoporosis, obesity, and sarcopenia
Sharda, N. K., & Colon-Emeric, C. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820088-9.00004-4 · Cited by 3
RANK-ligand inhibition to combat sarcopenia with underlying osteoporosis: a study protocol for a randomized, double-blind, double-dummy, active-controlled trial
Wong, R. M. Y., Wong, P. Y., Liu, C., Tang, N., Wan, R. C. W., Liu, W. H., Cui, C., Zhang, N., Kwok, T. C. Y., Law, S. W., et al. (2025) · Trials · doi:10.1186/s13063-025-08976-7 · Cited by 2
Low skeletal muscle index combined with reduced bone density increases mortality rate in older adults with heart failure
Wang, Q., Ye, Y., Zhang, S., Yang, J., Che, H., Qu, X., Qi, L., Li, M., & Shi, K. (2025) · Aging Clinical and Experimental Research · doi:10.1007/s40520-025-03213-2 · Cited by 2
Effect of Zoledronic Acid on Skeletal Muscle After Bariatric Surgery: A Secondary Analysis From a Randomized Controlled Trial
Gam, S., Hermann, A. P., Juhl, C. B., Hansen, S. G., & Gram, B. (2025) · Obesity · doi:10.1002/oby.70062 · Cited by 2
Denosumab ameliorates muscle indices in Chinese osteoporosis patients through clinical and bioinformatic evidence of RANKL in sarcopenia
Li, S., Hu, S., Zheng, X., Ku, X., Zou, J., Zhang, A., Nie, G., Liu, Y., Tian, C., Yan, M., et al. (2025) · iScience · doi:10.1016/j.isci.2025.114509 · Cited by 2
Gαi1/3 Is a Novel Regulatory Target for RANKL Signal Transduction and Osteoporosis
Bai, C., Zhang, M., Liu, L., Tao, L., Xu, C., Chai, H., Shi, X., Wang, Y., Zhang, X., Qiong, C., et al. (2026) · Advanced Science · doi:10.1002/advs.202510836 · Cited by 2
Is osteoporosis a driver or a passenger? Rethinking its role in age-related multimorbidity
Hu, C., Yin, H., Hu, X.-Y., Wang, Z., Xiao, X.-H., & Xie, H. (2026) · Advanced Orthopaedics · doi:10.1016/j.advop.2026.04.001 · Cited by 2
The crossroads between osteosarcopenia and intrinsic capacity—a narrative review
Neto, N. J., Hajj‐Boutros, G., Lok, W., Borda, M. G., Prokopidis, K., Rammal, H., Rivas, D., Samhat, H., Baltasar‐Fernandez, I., Imani, M., et al. (2026) · The Journals of Gerontology Series A · doi:10.1093/gerona/glag102 · Cited by 2
Quality of life of postmenopausal women with teriparatide, denosumab and alendronate: One-year prospective study with a propensity score-matched comparison
Lam, P. Y., Cheung, P. W. H., Lau, S. T., & Cheung, J. P. Y. (2022) · Journal of Orthopaedics Trauma and Rehabilitation · doi:10.1177/22104917221136282 · Cited by 2
Validating core therapeutic targets for osteoporosis treatment based on integrating network pharmacology and informatics
Weng, S., Fu, H., Shengxiang, X., & Li, J. (2024) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2024.100122 · Cited by 2
Recent Advances in Promoting Bone Regeneration in Type 2 Diabetes Using Drug Delivery Vehicles and Vehicle‐Free Therapeutics
Afsharian, Y. P., Rahimnejad, M., Rabiee, S. M., Feizi, F., & Seitz, H. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202400400 · Cited by 2
Effect of a single-dose denosumab on mineral homeostasis in infertile men: insights from a pilot intervention study and a randomized controlled trial
Yahyavi, S. K., Holt, R., Mortensen, L. J., Boisen, I. M., Árting, L. B., Jørgensen, A., Juul, A., & Jensen, M. B. (2025) · BMC Medicine · doi:10.1186/s12916-025-03958-7 · Cited by 2
Osteoblast MR deficiency protects against adverse ventricular remodeling after myocardial infarction
Wang, Y., Bai, L., Shi, X., Zhu, H., Du, L., Liu, Y., Ma, X., Lin, W.-Z., Liu, T., Sun, J., et al. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.03.003 · Cited by 2
Overexpressed RAD51 promoted osteogenic differentiation by activating IGF1R/PI3K/AKT pathway in osteoblasts
Qiu, M., Xie, Y., Tu, L., Zhao, M., Yang, M., Fang, L., & Gu, J. (2023) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5971 · Cited by 2
Does Denosumab Really Improve Muscle Strength? Current Evidence Is Weak
Beck, B. R., Scott, D., Daly, R. M., & Mesinovic, J. (2023) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.23.0039 · Cited by 2
Osteosarcopenia: The Modern Geriatric Giant
Zanker, J., Brennan-Olsen, S. L., & Duque, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11421-7 · Cited by 2
Long-term changes in lean mass in postmenopausal women and the effects of osteoporosis pharmacotherapy: A 10-year longitudinal study
Miyakoshi, N., Hongo, M., & Shimada, Y. (2021) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2021.02.002 · Cited by 2
Commentary on the effects of receptor activator of nuclear factor‐B ligand inhibition on bone mass and muscle strength
Hwang, J., Lien, A. S., & Jiang, Y. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13165 · Cited by 2
Muscles and bones
Hiruma, E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820088-9.00021-4 · Cited by 1
Bone turnover profile and muscular status in major orthopaedic surgery: a case series.
Bottai, V., Filoni, G., Andreani, L., Creati, G., Sacco, F. D., Bonadio, A. G., Giannotti, S., & Capanna, R. (2023) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v94i3.13880 · Cited by 1
Exploring influencing factors and predictive analysis of sarcopenia in the Chinese population using the body composition analyzer
Li, S., Zou, J., Wang, L., Nie, G., & Peng, W. H. (2024) · Science Progress · doi:10.1177/00368504241257047 · Cited by 1
Axillaridine A suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss via inhibition of RANKL-mediated RANK signaling pathways
Li, J., Xu, J., Jiang, Z., Duan, M., Yin, Y., Xiang, Z., Wang, X., Sheng, J., Liu, T., & Xu, H. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250397 · Cited by 1
SIRT1 Mediated by Baicalein and GFI1 Promotes Osteogenic Differentiation and Ameliorates Osteoporosis by Inhibiting Ferroptosis in Bone Marrow Mesenchymal Stem Cells
Bai, L., Wang, T., Zheng, J., Bian, C., Zhang, Y., & Fan, Y. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70368 · Cited by 1
Plasma metabolites mediate the causal effect of carbohydrate intake on bone mineral density
Zhao, X., & Chen, K. (2025) · Medicine · doi:10.1097/md.0000000000043608 · Cited by 1
Marine-derived natural products as anti-osteoporosis agents
Zheng, Q., Khan, S., Li, J., & Wang, T. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118284 · Cited by 1
Frailty Promotes Osteoporosis Development via Oxidative Stress: Evidence From Multicohort and Proteomic Analyses
Huang, H., Yu, J., LI, X., Ling, M., Zhang, C., & Fan, Y. (2025) · International Journal of Clinical Practice · doi:10.1155/ijcp/6662987 · Cited by 1
Modern Research on Traditional Chinese Ethnomedicines for Rheumatoid Arthritis: Acting Through Signaling Pathways
Tang, B., Fang, N., Wang, T., Meng, X., & Su, J. (2026) · Phytotherapy Research · doi:10.1002/ptr.70266 · Cited by 1
Anti–Receptor Activator of Nuclear Factor-κB Ligand Improves Muscle Dysfunction and Strengthens Bone in Laminin-α2–Deficient dy2J/dy2J Dystrophic Mice
Bouredji, Z., Facchin, A., Hamoudi, D., Yagita∥, H., Laroche, N., Marthe Rousseau, A., Argaw, A., & Frenette, J. (2026) · American Journal Of Pathology · doi:10.1016/j.ajpath.2026.04.011 · Cited by 1
Sex specific effects of irisin on the skeleton
Shimonty, A., & Bonewald, L. F. (2026) · Bone Research · doi:10.1038/s41413-026-00542-4 · Cited by 1
Comparison of Denosumab and Bisphosphonates for Sarcopenia in Postmenopausal Osteoporosis
Karaaslan, S., Hocaoğlu, E., & Ertürk, E. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15135010 · Cited by 1
Inhibition of membrane RANKL production in osteoblasts mediates curcumin-inhibited osteoclastogenesis
Gao, T., Ke, T., 肖展豪, & Gao, X. (2026) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2026e15332 · Cited by 1
Regulatory T cell induction strategies and applications in the treatment of immune and non-immune diseases
Chen, Y., Shi, Y., & You, J. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02910-2 · Cited by 1
Global loss of bone, muscle, and fat mass in a patient with juvenile Paget disease (hereditary hyperphosphatasia)
Theodorou, S. J., & Theodorou, D. J. (2022) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12559 · Cited by 1
Should we screen for sarcopenia in Romanian patients with osteoporosis? An overview of the current knowledge on osteosarcopenia
Mihai, G., & Pascanu, I. M. (2023) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2023-0014 · Cited by 1
Effect of denosumab on glucose metabolism in postmenopausal osteoporotic women with prediabetes: a study protocol for a 12-month multicenter, open-label, randomized controlled trial
Wang, Y., Jiang, Y., Li, J., Lin, X., Luo, Y., Tan, S., Yang, H., Gao, Z., Cui, X., Yin, P., et al. (2023) · Trials · doi:10.1186/s13063-023-07769-0 · Cited by 1
The role of osteoprotegerin (OPG) in exercise-induced skeletal muscle adaptation
Owens, A., Santos, L., Brook, M. S., Hunt, J. A., Piasecki, M., & Piasecki, J. (2024) · Translational Exercise Biomedicine · doi:10.1515/teb-2024-0033 · Cited by 1
Causal effects of the RANK-RANKL-OPG system and scoliosis: A bidirectional 2-sample Mendelian randomization study
Xie, W., Wan, W.-T., Liu, S.-Y., Wang, J., Chen, C., Sun, X., Liu, X.-Y., & Yang, Q. (2024) · Medicine · doi:10.1097/md.0000000000040934 · Cited by 1
Identification of Programmed Cell Death-related Biomarkers for the Potential Diagnosis and Treatment of Osteoporosis
Huo, Y., Guo, M., Li, Y., Yao, X., Tian, Q., & Liu, T. (2025) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303326112241021061805 · Cited by 1
The Interplay of Muscle and Bone in Later Life
Laskou, F., Dennison, E. M., & Patel, H. P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78128-6_10 · Cited by 1
Denosumab for the treatment of osteoporosis
McClung, M. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00075-7 · Cited by 2
Pharmacological management of osteosarcopenia
Feehan, J., & Duque, G. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820088-9.00003-2 · Cited by 1
Therapy-Induced Toxicities Associated with the Onset of Cachexia
Huot, J. R., Pin, F., & Bonetto, A. (2022) · Springer eBooks · doi:10.1007/978-3-031-09518-4_8 · Cited by 1
Post-fracture care program in Egypt: merging subsequent fracture prevention and improving patients’ outcomes—an initiative by the Egyptian Academy of Bone Health
Miedany, Y. M. E., Naby, M. M. H. E., Abu-Zaid, M. H., Mahran, S., Eissa, M., Saber, H. G., Tabra, S. A. A., Ibrahim, R. A., Galal, S., & Elwakil, W. (2023) · Egyptian Rheumatology and Rehabilitation · doi:10.1186/s43166-023-00173-1 · Cited by 1
Letter to the Editor: “Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment”
Sugiyama, T. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01241 · Cited by 1
Response to Letter to the Editor: “Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab Treatment”
Ferrari, S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01388
Uremic Solutes and Sarcopenia
Watanabe, H., Kato, H., Enoki, Y., Maeda, H., & Maruyama, T. (2020) · Springer eBooks · doi:10.1007/978-981-15-7793-2_9
Hip Fractures in Elderly Stroke Patients - The Role of Sarcopenia and Osteoporosis
Obiechina, N., Michael, A., Nandi, A., Adlakha, R., Davis, A., & Barnes, A. (2020) · International Journal of Clinical and Experimental Medical Sciences · doi:10.11648/j.ijcems.20200605.11
Ostéosarcopénie : vers la synthèse de deux entités ?
Chapurlat, R. D. (2021) · Revue du Rhumatisme Monographies · doi:10.1016/j.monrhu.2021.03.006
Osteoporose bei Diabetes mellitus
Tsourdi, E. A., & Hofbauer, L. C. (2021) · Diabetes aktuell · doi:10.1055/a-1508-3113
Energy metabolism in bone tumors
Bonnelye, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00014-1
Osteosarcopenia
Kirk, B., Zanker, J., Phu, S., & Duque, G. (2021) · doi:10.1002/9781119597896.ch11
Clinical Importance of Body Composition in Improving Bone Mineral Density of Femoral Neck After Denosumab Therapy in Patients With Rheumatoid Arthritis or Collagen Diseases
Nakano, M., Miyake, A., Egashira, R., Takeuchi, M., Moriguchi, M., Tonari, S., Saito, H., Nishikawa, H., Matsui, K., & Hagihara, K. (2022) · In Vivo · doi:10.21873/invivo.12853
Sarcopenia and Frailty Under Teriparatide Treatment: Coincidence or Consequence
Ata, A. M., Murat, K. A. R. A., Özgür, K. A. R. A., & Özçakar, L. (2021) · Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi · doi:10.31609/jpmrs.2021-84236
Effects of Zoledronate on Bone Mineral Density and Bone Turnover after Long-Term Denosumab Therapy: Observations in a Real-World SettingPreprint
Everts‐Graber, J., Reichenbach, S., Gahl, B., Häuselmann, H., Ziswiler, H., Studer, U., & Lehmann, T. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4106277
Denosumab and muscle performance
Rolvien, T., Rupp, T., Strahl, A., & Amling, M. (2022) · Osteoporosis International · doi:10.1007/s00198-022-06587-5
„Critical illness“: erhöhtes Frakturrisiko und potenzielle Gegenmaßnahmen
Kerschan‐Schindl, K. (2023) · Journal für Mineralstoffwechsel & Muskuloskelettale Erkrankungen · doi:10.1007/s41970-023-00221-4
Retracted Article: Investigating Psychic and Body Complications Caused by Inactivity Among Students of University During the COVID-19 Pandemic
Firouzjah, M. H., & Pourazar, M. (2023) · Practice in Clinical Psychology · doi:10.32598/jpcp.11.2.703.3
Retracted
TYPE 2 DIABETES AND BONE HEALTH: an epidemiological approach
Viggers, R. (2023) · doi:10.54337/aau561779793
The RANK-RANK-L-OPG pathway: trait d’union between bone and muscle
Iolascon, G., Liguori, S., Paoletta, M., Tomaino, F., & Moretti, A. (2023) · International Journal of Bone Fragility · doi:10.57582/ijbf.230302.056
Ethnic Variations in the Levels of Bone Biomarkers (Osteoprostegerin, Receptor Activator of Nuclear Factor Kappa-Β Ligand and Glycoprotein Non-Metastatic Melanoma Protein B) in People with Type 2 Diabetes
Cherian, P., Al‐Khairi, I., Abu‐Farha, M., Alramah, T., Albatineh, A. N., Alhomaidah, D. S., Safadi, F. F., Ali, H., Abdul‐Ghani, M. A., Tuomilehto, J., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12051019
Ostéoporose
Philippoteaux, C. (2024) · Revue du Rhumatisme · doi:10.1016/j.rhum.2024.07.005
Review of osteokines in spinal cord injury: potential biomarkers during rehabilitation
Liu, J., Yang, J., Wu, Q., Fang, Z., Wang, T., Wang, Z., & Xu, D. (2025) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-024-05415-2
Sarcopenia and Osteoporosis: Two Sides of the Same Coin
Anil, A., Agrawal, S., Panthackel, M., & Dave, B. R. (2025) · Indian Spine Journal · doi:10.4103/isj.isj_91_24
Therapeutic potential of FGF19 in combatting osteosarcopenia: effects on muscle strength and bone health in aged male mice
Zhang, H., Garg, P., Benoit, B., Pinteur, C., Chanon, S., Vieille‐Marchiset, A., Loizon, E., Beau, A., Laroche, N., Ruzzin, J., et al. (2025) · JBMR Plus · doi:10.1093/jbmrpl/ziaf157
Novel Function of Osteoprotegerin in the Modulation of Glucose Metabolism in the Liver via mTORC1
Qiu, S., Wang, X., Li, K., Zhang, S., Lai, Y., Mi, Q., Yang, M., Liu, D., Li, L., Wu, Q., et al. (2025) · Diabetes · doi:10.2337/db25-0207
Insulin and Bone
Diana, R., & Luzi, L. (2025) · Springer eBooks · doi:10.1007/978-3-032-01700-0_11
Association of baseline osteocalcin and femoral neck bone mineral density in healthy women with future risk of fractures, cardiovascular disease, diabetes and death
Pan, Z.-C., Yang, Y., Chen, X., Jiang, T., Song, J., Sheng, C.-X., Wang, Y.-Z., Xu, M., Deng, Y., Yu, G., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1652769 · Cited by 1
The health protection potential of total flavonoids of Rhizoma Drynariae in an aging society
Zheng, Y., Li, J., Chen, X., Ma, B., Chen, K., & Yu, F. (2025) · Biomedical Analysis · doi:10.1016/j.bioana.2025.11.001
Du besoin de revisiter l’ostéosarcopénie par l’apport du microbiote intestinal
Cailleaux, P. (2025) · Revue du Rhumatisme · doi:10.1016/j.rhum.2025.11.004
Additional file 2 of Effect of denosumab on glucose metabolism in postmenopausal osteoporotic women with prediabetes: a study protocol for a 12-month multicenter, open-label, randomized controlled trial
Wang, Y., Jiang, Y., Li, J., Lin, X., Luo, Y., Tan, S., Yang, H., Gao, Z., Cui, X., Yin, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26655667
Additional file 1 of Effect of denosumab on glucose metabolism in postmenopausal osteoporotic women with prediabetes: a study protocol for a 12-month multicenter, open-label, randomized controlled trial
Wang, Y., Jiang, Y., Li, J., Lin, X., Luo, Y., Tan, S., Yang, H., Gao, Z., Cui, X., Yin, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26655664
Association between the sarcopenia index and osteoarthritis: a cross-sectional and longitudinal study
Cai, X., Lan, T., Jiang, Z. S., Tang, F., & Fan, H. (2026) · European journal of medical research · doi:10.1186/s40001-026-03891-2
Superior Efficacy of Denosumab Over Zoledronic Acid in Increasing Femoral Neck Bone Mineral Density in Osteoporosis Patients With Type 2 Diabetes Mellitus
Han, D., Li, B., Liu, J., Chen, L., Wang, H., Yuan, L., Xuan, M., & Song, L. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.01.022
Molecular mechanisms and preclinical evidence of natural products in diabetic osteoporosis: a review
Zhou, T., Yu, Y., Yang, S., Fan, X. Y., Yu, R., & Zhang, G. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1793925
Biomimetic Nanoparticles for Bone Regeneration: Construction Strategies and Therapeutic Mechanisms
Wang, Z., Shen, N., Yang, T., Dong, S., Kaige, X., Zhao, K., Zhang, Y., Jiang, Y., & Li, T. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s589003
Effects of Denosumab on Glycemic Control in Patients with Osteoporosis: A Systematic Review and Meta-Analysis
Koo, H., Park, K., Kim, D., & Lee, Y. J. (2026) · Drug Targets and Therapeutics · doi:10.58502/dtt.25.0019
Age-dependent musculoskeletal changes during mechanical unloading with bisphosphonate treatment
Orr, S. V., Gilmore, N. K., Pathak, S. J., Edan, H. A., Langer, H. T., Baar, K., & Christiansen, B. (2026) · Bone · doi:10.1016/j.bone.2026.117924
Modulating ER-mitochondrial crosstalk to revitalize implant osseointegration in diabetes through an injectable hydrogel platform
Wang, H., Qin, Z., Liu, B., Li, C., Ruan, Y., Shen, Y., Li, H., Zhao, I. S., & Gan, X. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.177208
A proteomic atlas phenotyping Fabry disease identifies a precise cardiovascular risk signature that integrates mitochondrial and lysosomal pathways
Santulli, G., Pande, S., & Varzideh, F. (2026) · Journal of Molecular Medicine · doi:10.1007/s00109-026-02682-w
Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling
Ahmad, T., Ahmad, S. S., Ahmed, F., Haider, M. R., Goel, D., Vohora, D., & Sharma, M. (2026) · 3 Biotech · doi:10.1007/s13205-026-04889-7

Authors: Bonnet, N., Bourgoin, L., Biver, E., Douni, E., & Ferrari, S.
Affiliations: University Hospital of Geneva (CH)
Agricultural University of Athens (GR)
Corresponding author: Bonnet, Nicolas
ORCID: Bonnet, Nicolas
Biver, Emmanuel
Douni, Eleni
Ferrari, Serge
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2019-07-02
Volume: 129
Issue: 8
Pages: 3214-3223
ISSN: 0021-9738 (ISSN-L)
1558-8238
DOI: 10.1172/jci125915
PMC: PMC6668701
OpenAlex: W2945787015
Cited by: 314
References: 41
Citations by year: 2026: 39 · 2025: 48 · 2024: 42 · 2023: 48 · 2022: 45 · 2021: 46 · 2020: 36 · 2019: 10
FWCI: 11.34
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
Funders: Swiss National Science Foundation grant (No 3100A0-116633/1)
European Foundation for the Study of Diabetes (ME1598)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Keywords: RANKL inhibition, denosumab, osteoprotegerin, muscle strength, insulin sensitivity, sarcopenia, osteoporosis, PPARδ, muscle atrophy, muscle fiber composition, myostatin, PTEN, skeletal muscle glucose uptake, muscle inflammation, bisphosphonates, osteoclastogenesis
MeSH terms: Denosumab, Animals, Bone and Bones, Cell Line, Female, Humans, Insulin Resistance, Male, Mice, Transgenic, Organ Size, Osteoporosis, PPAR-beta, Mice, Osteoprotegerin, RANK Ligand, Muscle Strength, Sarcopenia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks